Monitor the implementation of the FY2013 Continuing Appropriations Act, P.L. 113-6. H.R.2708,  To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes.  Provisions related to specific tariffs. H.R. 3309, the Innovation Act. Monitored legislative and federal activity related to intellectual property protection. S1106, Sensible Accounting to Value Energy Act of 2013.
All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
Need for tranparency on the CMS preventative maintenance directive for medical equipment. S696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management.
S1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management. S. 954,   Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators.H.R. 1947,  Federal Agriculture Reform and Risk Management Act of 2013. 
Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Biotechnology, Winter Wheat Cereals Project and Pollinators.

S. 809/H.R. 1699,  Genetically Engineered Food Right-to-Know Act.
Provisions related to labeling.  

H.R.2692, Saving America's Pollinators Act of 2013. 
Provisions related to suspension of pesticide registrations.  

H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013. Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency H.R. 1150, Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases.  Title II, General provisions in the bill.
S. 1256, Preventing Antibiotic Resistance Act of 2013. A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases.S.959/HR 3204,  Pharmaceutical Compounding Quality and Accountability Act. General provisions of the bill.

HR 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.  

Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. S761, Energy Savings and Industrial Competitiveness Act of 2013.  All measures related to energy efficiency.
S1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013.  All measures pertaining to requirements to eliminate fossil fuels by 2030.S1392/ HR 1616, Energy Savings and Industrial Competitiveness Act of 2013 - all provisions pertaining to the Shaheen Portman Act  S. 761  regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards S 553/HR 1125, Veterinary Medicine Loan Repayment Program Enhancement Act. HR 3204, Drug Quality and Security Act. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
HOM - Homeland Security TAR - Tariff (miscellaneous tariff bills) CPT - Copyright/Patent/Trademark BAN - Banking MMM - Medicare/Medicaid CHM - Chemicals/Chemical Industry AGR - Agriculture TAX - Taxation/Internal Revenue Code HCR - Health Issues ENG - Energy/Nuclear EDU - Education PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAYER CORPORATION (CONSOLIDATED REPORT)
801 Pennsylvania Ave., NW Suite 900, WASHINGTON, DC, 20004, US
DONNA STEPHENS JEAN D REIMERS MATTHEW GRIERSON PERIN JULIE CORCORAN THOMAS B LILBURN JULIANE H VAN EGMOND DAKOTAH SMITH THOMAS B LILBURN ROBERT D THOMAS JULIANE H VAN EGMOND DAKOTAH SMITH JEAN D REIMERS MATTHEW GRIERSON PERIN DAKOTAH SMITH JULIANE H VAN EGMOND DONNA STEPHENS JULIE CORCORAN THOMAS B LILBURN DAKOTAH SMITH JULIANE H VAN EGMOND DONNA STEPHENS THOMAS B LILBURN